| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIG | Common Stock | Options Exercise | $875,099 | +36,236 | +25% | $24.15 | 179,511 | 30 Nov 2022 | Direct | |
| transaction | HIG | Common Stock | Sale | $2,759,973 | -36,236 | -20% | $76.17 | 143,275 | 30 Nov 2022 | Direct | F1, F2 |
| holding | HIG | Common Stock | 43,179 | 30 Nov 2022 | By Spouse | ||||||
| holding | HIG | Common Stock | 95,386 | 30 Nov 2022 | Swift Family Gift Trust | ||||||
| holding | HIG | Common Stock | 60,865 | 30 Nov 2022 | Swift Family Legacy Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HIG | Stock Option | Options Exercise | $0 | -36,236 | -100% | $0.000000* | 0 | 30 Nov 2022 | Common Stock | 36,236 | $24.15 | Direct | F3 |
| holding | HIG | Stock Option | 103,872 | 30 Nov 2022 | Common Stock | 103,872 | $35.83 | Direct | F4 | |||||
| holding | HIG | Stock Option | 301,887 | 30 Nov 2022 | Common Stock | 301,887 | $41.25 | Direct | F5 | |||||
| holding | HIG | Stock Option | 294,481 | 30 Nov 2022 | Common Stock | 294,481 | $43.59 | Direct | F6 | |||||
| holding | HIG | Stock Option | 302,908 | 30 Nov 2022 | Common Stock | 302,908 | $48.89 | Direct | F7 | |||||
| holding | HIG | Stock Option | 352,263 | 30 Nov 2022 | Common Stock | 352,263 | $49.01 | Direct | F8 | |||||
| holding | HIG | Stock Option | 310,820 | 30 Nov 2022 | Common Stock | 310,820 | $51.87 | Direct | F9 | |||||
| holding | HIG | Stock Option | 284,819 | 30 Nov 2022 | Common Stock | 284,819 | $53.81 | Direct | F10 | |||||
| holding | HIG | Stock Option | 327,679 | 30 Nov 2022 | Common Stock | 327,679 | $55.27 | Direct | F11 | |||||
| holding | HIG | Stock Option | 301,932 | 30 Nov 2022 | Common Stock | 301,932 | $69.41 | Direct | F12 |
| Id | Content |
|---|---|
| F1 | The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on March 15, 2022, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2013 and scheduled to expire on March 5, 2023. |
| F2 | Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $76.00 - $76.40 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | The options became fully exercisable on March 5, 2016, the third anniversary of the grant date. |
| F4 | The options became fully exercisable on March 4, 2017, the third anniversary of the grant date. |
| F5 | The options became fully exercisable on March 3, 2018, the third anniversary of the grant date. |
| F6 | The options became fully exercisable on March 1, 2019, the third anniversary of the grant date. |
| F7 | The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. |
| F8 | The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
| F9 | One-third of the options became exercisable on February 23, 2022, an additional one-third of the options will become exercisable on February 23, 2023 and the remaining one-third of the options will become exercisable on February 23, 2024, the third anniversary of the grant date. |
| F10 | The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
| F11 | One-third of the options became exercisable on February 25, 2021, an additional one-third of the options became exercisable on February 25, 2022 and the remaining one-third of the options will become exercisable on February 25, 2023, the third anniversary of the grant date. |
| F12 | One-third of the options will become exercisable on February 23, 2023, an additional one-third of the options will become exercisable on February 23, 2024 and the remaining one-third of the options will become exercisable on February 23, 2025, the third anniversary of the grant date. |